Patents by Inventor Hassan Pajouhesh

Hassan Pajouhesh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040259866
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: April 9, 2004
    Publication date: December 23, 2004
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Francesco Belardetti, Hossein Pajouhesh
  • Publication number: 20040209872
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: December 23, 2003
    Publication date: October 21, 2004
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • Patent number: 6784202
    Abstract: The present invention relates to therapeutically active cubane compounds, a method of preparing the same, and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating diseases of the central nervous system related to the metabotropic glutamate receptor system.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: August 31, 2004
    Assignee: Prescient NeuroPharma Inc.
    Inventors: Hassan Pajouhesh, Kenneth Curry
  • Publication number: 20040147529
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: September 3, 2003
    Publication date: July 29, 2004
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • Publication number: 20040147482
    Abstract: Thee present invention relates to therapeutically active cubane compounds, a method of preparing the same, and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in creating diseases of the central nervous system related to the metabotropic glutamate receptor system.
    Type: Application
    Filed: January 14, 2004
    Publication date: July 29, 2004
    Applicant: Prescient NeuroPharma Inc.
    Inventors: Hassan Pajouhesh, Kenneth Curry
  • Publication number: 20040044004
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: April 8, 2003
    Publication date: March 4, 2004
    Applicant: NeuroMed Technologies, Inc.
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • Publication number: 20040034035
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: April 8, 2003
    Publication date: February 19, 2004
    Applicant: NeuroMed technologies, Inc.
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti